IBRN vs MDEV: Holdings Overlap & Returns

Over the year to Nov 13, 2026, IBRN returned +19.8% to MDEV's +8.8%; 0% of their weight is in the same names.

Return gap
+11.0 pts1 year to Nov 13, 2026: IBRN ahead, total return
Fee gap
0.23 ptsA year: IBRN 0.47%, MDEV 0.70%, per filings dated Nov 21, 2025 and Jul 29, 2026
Overlap
0%Share of the two books held in common, holdings dated Nov 12, 2026
Net flow
+$2m / $0kIBRN / MDEV, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
IBRN and MDEV · 1 year

Growth of 100

IBRN +19.8%MDEV +8.8%
Growth of 100 in IBRN and MDEV over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. IBRN ends at 119.8 (+19.8%), MDEV at 108.8 (+8.8%).

IBRN +19.8%, MDEV +8.8%: IBRN +11.0 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

IBRN and MDEV flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in IBRN costs about $16.00 one way and $32.00 in and out, at a median spread of 0.32%. The 0.32% spread is IBRN’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in MDEV for 10 years at 0.70% a year costs about $1,148 in fees and lost growth; IBRN at 0.47% would cost $778. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

IBRN · 1 year to Nov 13, 202695% of its weight is outside the S&P 500
95% of its weight is outside the S&P 5005% of IBRN's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 12, 2026.5%95%inof its weight outside the S&P 500active share 100% · top ten 45% of the fund · 67 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 0% in95% of its weight is outside the S&P 5005% of IBRN's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 12, 2026.5%95%5% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · Nasdaq-100: 0% in

5% of IBRN's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 12, 2026.

MDEV · 1 year to Nov 13, 202652% of its weight is outside the S&P 500
52% of its weight is outside the S&P 50048% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.48%52%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 98% · top ten 23% of the fund · 50 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 6% in52% of its weight is outside the S&P 50048% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.48%52%in the S&P 500outside the S&P 500active share 98% · Nasdaq-100: 6% in

48% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.

Key numbers

IBRN in the S&P 500
5.3%
MDEV in the S&P 500
47.8%
IBRN total return, 1 year
+19.8%
MDEV total return, 1 year
+8.8%

IBRN costs 0.23 points a year less; their one-year returns differ by 11.0 points; IBRN is 2.5 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+19.8%+8.8%
Below its all-time high15.9%, high on Aug 19, 202619.1%, high on Sep 7, 2021
What it tracksTherapeutics and medical devicesTherapeutics and medical devices
Expense ratio0.47%0.70%
Net assets, as of Nov 12, 2026$8.6m$3.4m
Holdings in common0%

The numbers behind it

Net assets on Nov 12, 2026: $8.6m for iShares Neuroscience and Healthcare ETF and $3.4m for First Trust Indxx Medical Devices ETF.

Holdings in common uses holdings dated Nov 12, 2026.

What they share

By the books each fund has filed, IBRN and MDEV hold 0% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026.

0half (50%)100%

half

0% in common

Only in IBRN

Show all 8 holdings
BIOGEN5.33%
NEUROCRINE BIOSCIENCES5.09%
EDGEWISE THERAPEUTICS4.96%
Alkermes Public Limited Company4.75%
ARGENX SE ADR4.43%
PRAXIS PRECISION MEDICINES4.30%
PTC THERAPEUTICS4.29%
AXOGEN4.28%

Only in MDEV

Show all 8 holdings
GE HealthCare Technologies Inc.2.35%
Edwards Lifesciences Corporation2.34%
Koninklijke Philips N.V.2.33%
Teleflex Incorporated2.31%
Straumann Holding AG (Registered)2.24%
Steris Plc2.23%
LivaNova Plc2.22%
Becton, Dickinson and Company2.21%

Side by side

Open the table
FundiShares Neuroscience and Healthcare ETF · Holds 67 stocks in therapeutics and medical devices, 5% of its weight in S&P 500 companiesFirst Trust Indxx Medical Devices ETF · Holds 50 stocks in therapeutics and medical devices, 48% of its weight in S&P 500 companies
IssueriSharesFirst Trust
ThemeTherapeutics and medical devicesTherapeutics and medical devices
In the S&P 5005.3%47.8%
Active share vs the S&P 500100.0%98.0%
In the Nasdaq-1000.0%6.1%
Holdings6750
Top ten, share of the fund45.2%22.6%
Expense ratio0.47%0.70%
Fee for the differing part0.47%0.71%
Total return, 1 year+19.8%+8.8%
vs its benchmarknot measurednot measured
Below its high−15.9%−19.1%
Net assets, as of Nov 12, 2026$8.6m$3.4m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months−12.6%+5.5%
6 months−1.7%+26.9%
1 year+19.8%+8.8%
3 years+67.5%+27.4%
Since launch (Not the same days: IBRN Aug 2022 · MDEV Jun 2021)+41.2%−10.2%

About IBRN

By weight, 5% of IBRN's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 45% of the fund across 67 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +19.8% with distributions reinvested. It sits 15.9% below its all-time high of Aug 19, 2026.

About MDEV

By weight, 48% of MDEV's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 23% of the fund across 50 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +8.8% with distributions reinvested. It sits 19.1% below its all-time high of Sep 7, 2021.

0% of the two portfolios are the same securities at the same weight.

Questions people ask

Do IBRN and MDEV hold the same stocks?

By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, IBRN or MDEV?

IBRN has 5% of its weight in S&P 500 names and MDEV has 48%, so IBRN differs more from the index.

Which is cheaper, IBRN or MDEV?

IBRN charges 0.47% a year and MDEV charges 0.70%, so IBRN is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, IBRN against MDEV, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ibrn-vs-mdev

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.